Presentation AATS 2013 They Are Paying US What?! Can TAVR Ever be Financially Viable? Presenter: Wilson Y. Szeto May 08, 2013 REGISTER for free or LOG IN to view this content Aortic Valve Presentation AATS 2013 Up Next Presentation Cause of Death Within 30 Days of PCI in an Era of Mandatory Outcome Reporting Presenter: Aggarwal May 08, 2013 More slides + Presentation AATS 2013 Commercialization of TAVR in the US: What is the Strategy? Presenter: Kristen Skelton May 08, 2013 Presentation Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial Presenter: 221201|Masahiro Natsuaki May 08, 2013 We Recommend
Presentation Cause of Death Within 30 Days of PCI in an Era of Mandatory Outcome Reporting Presenter: Aggarwal May 08, 2013
Presentation AATS 2013 Commercialization of TAVR in the US: What is the Strategy? Presenter: Kristen Skelton May 08, 2013
Presentation Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial Presenter: 221201|Masahiro Natsuaki May 08, 2013